NCT Number: NCT01906502
24-hour IOP Pattern With SENSIMED Triggerfish® in a Healthy Population
A database (Snapfish) has been generated at Sensimed compiling all data acquired up to now on healthy volunteers and patients with glaucoma. However, healthy subjects were much younger than glaucoma patients. Additionally, the number of glaucoma patients in Snapfish database was almost twice higher than the number of healthy subjects. As it is generally accepted that intra ocular pressure (IOP) in the aging population is higher than IOP in young adults it is of interest to evaluate the 24-hour IOP pattern of older healthy subjects. Furthermore, improving our knowledge of the "healthy" 24-hour IOP pattern in comparison to glaucoma profiles would be beneficial for management of glaucoma.
Looking for future studies?
Notify MeKey information
Conditions
Age range
40 year–80 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Meir Medical Center, Kfar Saba, Israel
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Subject of Caucasian origin
- Healthy subject without previous ocular disease
- Aged between 40 and 80 years, of either sex
- Not more than 6 diopters spherical equivalent in the study eye
- Having given written informed consent, prior to any investigational procedures
Exclusion criteria
- Corneal or conjunctival abnormality precluding contact lens adaptation
- Previous refractive surgery
- Occludable or closed iridocorneal angle
- Sleep apnea syndrome
- Subjects with allergy to corneal anesthetic
- Subjects with contraindications for silicone contact lens wear
- Subjects not able to understand the character and individual consequences of the investigation
- Participation in other clinical research within the last 4 weeks
Treatment and study plan
Primary outcomes
-
The 24-hour IOP pattern recorded with Sensimed Triggerfish (TF) in healthy subjects, aged between 40 and 80 years Secondary
Time frame: 24-hour
Secondary outcomes
-
Diurnal and nocturnal IOP patterns in healthy subjects
Time frame: 24 hours
-
Assessment of corneal biomechanical properties in healthy population (if available)
Time frame: 24 hours
-
Relationship between the 24-hour IOP pattern monitored by TF and the 24-hour blood pressure pattern in healthy subjects (if available)
Time frame: 24 hours
-
Assessment of Safety and tolerability through adverse events
Time frame: 6 months
Sponsors and collaborators
Lead sponsor
Sensimed AG
Industry
Registry information
Official study title
A Prospective, Open Label Study to Assess the 24-hour IOP Pattern Recorded With SENSIMED Triggerfish® in a Healthy Population
Important dates
- Study start
- 2013
- Primary completion
- 2014
- Study completion
- 2014
- First posted
- Jul 24, 2013
- Registry last updated
- Aug 26, 2014
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
The Peer Genetic Study
NCT05011799
Genital Diseases, Genital Diseases, Male
Philadelphia, Pennsylvania, United States
View Trial DetailsInvestigation of Docosahexaenoic Acid (DHA) Metabolic Pathway in Human by Using 13C Labeled Molecules
NCT02168738
Healthy Subject
Pierre-Bénite, France
View Trial DetailsProject Self in Improving Cervical Cancer Screening Rates in Hispanic and African American Women
NCT04614155
Healthy Subject
Houston, Texas, United States
View Trial DetailsBioequivalence Study betweenYHP2406 and YHR2501 in Healthy Subjects
NCT06920719
Healthy Subject
Seoul, South Korea
View Trial Details